Please login to the form below

Not currently logged in
Email:
Password:

AS

This page shows the latest AS news and features for those working in and with pharma, biotech and healthcare.

EU “still interested” in Valneva COVID vaccine despite UK snub

EU “still interested” in Valneva COVID vaccine despite UK snub

Negotiations between Valneva and the EU are “ongoing and advanced”, with its vaccine candidate VLA2001 touted as a potential booster shot in France. ... The EU is still interested in this vaccine,” said the source, suggesting that the Valneva

Latest news

  • Orphan status in Europe for lymphoma drug Zynlonta Orphan status in Europe for lymphoma drug Zynlonta

    We are committed to providing global access to Zynlonta for as many patients as may benefit.”. ... ZYNLONTA is also in late-stage clinical trials in combination with other agents and is being evaluated as a monotherapy.

  • UK announces COVID boosters for a “bumpy winter” ahead UK announces COVID boosters for a “bumpy winter” ahead

    The government is already offering booster shots to half a million people who are classed as clinically extremely vulnerable. ... The main aim of the booster programme is to prolong that protection and reduce serious disease as we head towards the colder

  • Valneva shares fall as UK cancels COVID-19 vaccine order Valneva shares fall as UK cancels COVID-19 vaccine order

    However, none of these scenarios are evident as an explanation for the sudden termination. ... This has come as a huge blow to my constituency.”. VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials

  • Embattled Biogen talks up Aduhelm Embattled Biogen talks up Aduhelm

    He cited three near-term priorities for the company as it seeks to overcome the many hurdles in the way of its drug. ... pathway. With more than six million Americans living with Alzheimer’s disease, the price tag to the US healthcare system will be

  • Behaviour change theory Behaviour change theory

    Hmmm. As an added boon for marketers, the op-ed proffered advice on how to ‘get patients or HCPs to do something different’. ... It’s not new, it’s just been given a label as a behaviour change technique.

More from news
Approximately 2 fully matching, plus 7,549 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1,344 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1,186 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 1,062 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...